Immunology / Oncology
www.odysseytx.com
HBM contact: Dr Emil Bujak
Company status: private
Odyssey harnesses its world-class discovery engine with the aim of developing transformative medicines for diseases caused by immune dysfunction and cancer
© HBM Partners AG | Bundesplatz 1 | 6300 Zug, Switzerland | Phone +41 43 888 7171